Heart failure: The need for global health perspective

Current Cardiology Reviews

Volumn 9, Issue 2, 2013, Pages 97-98

  Banerjee, Amitava ^a   Mendis, Shanthi ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Epidemiology; Heart failure; Prevention; Prognosis; Treatment; Valve disease

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT;

ATTITUDE TO HEALTH; CARDIOMYOPATHY; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CHAGAS DISEASE; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; EDITORIAL; HEALTH CARE POLICY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; INCIDENCE; MORBIDITY; PRACTICE GUIDELINE; PREVENTION AND CONTROL; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATIC HEART DISEASE; RISK FACTOR; UNITED NATIONS; COST OF ILLNESS; HEALTH; HEALTH CARE DELIVERY; STATISTICS AND NUMERICAL DATA; STATISTICS;

COST OF ILLNESS; GLOBAL HEALTH; HEALTH SERVICES ACCESSIBILITY; HEART FAILURE; HUMANS; PRIMARY PREVENTION; WORLD HEALTH;

EID: 84894387958     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/1573403X11309020001     Document Type: Editorial

References (32)

1. World Health Organization. The Global Burden of Disease: 2004 Update. World Health Organization, Geneva, Switzerland (2008).
2. Beaglehole R, Ebrahim S, Reddy KS, et al. Prevention of chronic diseases: a call to action. Lancet 2007; 370: 2152-2157.
3. Daar AS, Singer PA, Persad DL, et al. Grand challenges in chronic non-communicable diseases. Nature 2007; 450: 494-496.
4. Sanderson JE, Mayosi B, Yusuf S, et al. Global burden of cardiovascular disease. Heart 2007; 93: 1175.
5. Beaglehole R, Bonita R, Alleyne G, et al. UN High-Level Meeting on Non-Communicable Diseases: addressing four questions. Lancet. 2011; 378: 449-455.
6. Haeusler KG, Laufs U, Endres M. Chronic heart failure and ischemic stroke. Stroke 2011; 42: 2977-2982.
7. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011; 8: 30-41.
8. Karthikeyan G, Zühlke L, Engel M, et al. Rationale and design of a Global Rheumatic Heart Disease Registry: the REMEDY study. Am Heart J 2012; 163: 535-40e1.
9. Ranasinghe I, Naoum C, Aliprandi-Costa B, et al. Management and outcomes following an acute coronary event in patients with chronic heart failure 1999-2007. Eur J Heart Fail; 14: 464-472.
10. Loehr LR, Rosamond WD, Poole C, et al. The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study. Am J Epidemiol 2010; 172: 781-789.
11. Levenson JW, Skerrett PJ, Gaziano JM. Reducing the global burden of cardiovascular disease: the role of risk factors. Prev Cardiol 2002; 5: 188-199.
12. Bloom DE, Cafiero ET, Jané-Llopis E, et al. The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum 2011.
13. Guo Y, Banerjee A. Heart failure in East Asia. Curr Cardiol Rev 2013.
14. Harikrishnan S, Ganapathi S. Heart failure in South Asia. Curr Cardiol Rev 2012.
15. Guha K, McDonagh T. Heart Failure Epidemiology: European Perspective. Curr Cardiol Rev 2012.
16. Al-Shamiri MQ. Heart failure in the Middle East. Curr Cardiol Rev 2012.
17. Bocchi EA. Heart Failure in South America. Curr Cardiol Rev 2012.
18. Blair J, Huffman M, Shah S. Heart Failure in North America. Curr Cardiol Rev 2012.
19. Ajay VM, Prabhakaran D. Editorial. Heart failure: meeting the challenges of surveillance and knowledge translation in resource-poor settings. Curr Cardiol Rev 2012.
20. Bloomfield G, Mocumbi A. Heart failure in the African context. Curr Cardiol Rev 2012.
21. Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011; 378: 1231-1243.
22. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Euro Heart J 2012; 33: 1787-1847.
23. Hunt SA, Abraham WT, Chin MH, et al. Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009; 53: e1-e90.
24. van Mourik MS, Cameron A, Ewen M, et al. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data. BMC Cardiovasc Disord 2010; 10: 25.
25. Swedberg K, Komajda M, Böhm M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010; 376: 875-885.
26. Huffman MD, Prabhakaran D. Heart failure: epidemiology and prevention in India. Natl Med J India 2010; 23: 283-288.
27. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012; 33: 2551-2567.
28. Mohanan PP, Mathew R, Harikrishnan S, et al. Presentation, management, and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS Registry. Eur Heart J 2012 Sep 7.
29. Kakkar AK, Mueller I, Bassand JP et al. International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). Am Heart J. 2012; 163: 13-19e1.
30. Endres M, Heuschmann PU, Laufs U, Hakim AM. Primary prevention of stroke: blood pressure, lipids, and heart failure. Eur Heart J 2011; 32: 545-552.
31. World Health Organization, Package of Essential Noncommunicable Disease Interventions for Primary Care in low resource settings World Health Organization, Geneva 2010.
32. Fuster V, Kelly BB, Vedanthan R. Global cardiovascular health: urgent need for an intersectoral approach. J Am Coll Cardiol 2011; 58: 1208-1210.